#1 out of 30.00%
celebrities2h ago
Joe Rogan podcast appearance tied to rise in demand for alternative cancer treatment
- After Mel Gibson's appearance on Joe Rogan, prescribing of ivermectin–benzimidazole nearly doubled nationwide.
- The study found larger prescription increases among men, White patients, ages 18–64, and southern residents.
- Researchers noted the study was observational and could not prove Gibson's appearance caused the spike.
- No clinical trials currently support the safety or effectiveness of ivermectin–benzimidazole for cancer.
- Experts say patients should consult qualified healthcare professionals before pursuing such treatments.
- The research analyzed real-world prescribing data and is limited to observational findings.
- The episode reportedly drew 60 million views in the month after airing, amplifying its potential impact.
- Researchers cited possible non-prescription purchases as a factor in the prescription spike.
- The study did not assess whether patients used ivermectin with standard cancer therapies.
- Clinicians emphasized seeking professional medical guidance amid speculative off-label use.
Vote 0


